Cantel Medical Corp. (NYSE:CMD) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $105.41 and last traded at $102.97, with a volume of 144200 shares traded. The stock had previously closed at $103.65.

CMD has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Cantel Medical Corp. from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a research report on Tuesday, August 1st. Sidoti upgraded Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Wednesday, August 2nd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical Corp. in a research report on Friday, September 1st. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $91.67.

The company has a quick ratio of 1.49, a current ratio of 2.41 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $4,330.00, a PE ratio of 49.83 and a beta of 1.23.

Cantel Medical Corp. (NYSE:CMD) last released its quarterly earnings results on Thursday, September 28th. The company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.02. Cantel Medical Corp. had a return on equity of 17.60% and a net margin of 9.27%. The business had revenue of $205.50 million for the quarter, compared to the consensus estimate of $200.32 million. The business’s revenue was up 14.8% compared to the same quarter last year. sell-side analysts expect that Cantel Medical Corp. will post 2.34 earnings per share for the current year.

The company also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Wednesday, January 17th will be given a dividend of $0.085 per share. This is an increase from Cantel Medical Corp.’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. This represents a yield of 0.17%. Cantel Medical Corp.’s dividend payout ratio (DPR) is presently 8.19%.

In other Cantel Medical Corp. news, Director Mark N. Diker sold 7,000 shares of the firm’s stock in a transaction dated Tuesday, October 3rd. The stock was sold at an average price of $98.90, for a total transaction of $692,300.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Eric W. Nodiff sold 2,868 shares of the firm’s stock in a transaction dated Friday, October 20th. The shares were sold at an average price of $97.55, for a total value of $279,773.40. Following the sale, the executive vice president now owns 39,102 shares in the company, valued at approximately $3,814,400.10. The disclosure for this sale can be found here. Insiders have sold 36,368 shares of company stock worth $3,576,028 in the last 90 days. Company insiders own 14.90% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Parametric Portfolio Associates LLC purchased a new stake in Cantel Medical Corp. during the second quarter valued at about $4,820,000. Principal Financial Group Inc. purchased a new stake in Cantel Medical Corp. during the second quarter valued at about $21,919,000. Rhumbline Advisers purchased a new stake in Cantel Medical Corp. during the second quarter valued at about $5,892,000. Koch Industries Inc. purchased a new stake in Cantel Medical Corp. during the second quarter valued at about $407,000. Finally, Bank of New York Mellon Corp purchased a new stake in Cantel Medical Corp. during the second quarter valued at about $38,718,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/11/21/cantel-medical-corp-cmd-sets-new-12-month-high-at-105-41.html.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.